Commencement of U.S.A. Operations at LabCentral in Boston, MA.
Braizon Therapeutics is proud to announce that from April 1st 2019 we will begin operating in the United States of America within the startup incubator and launchpad LabCentral, located in Kendal Square, Cambridge.
With this expansion of our operations we hope to enable smooth joint research operations with existing and future Biotech and Pharma partners in North America.
Initially opened in November 2013 and expanded in December 2017 to accommodate successfully growing graduates of the first facility, LabCentral is supported by major pharmaceutical companies, the Massachusetts Life Sciences Center, and MIT. This first-of-a-kind shared lab space has helped scientists and entrepreneurs grow high-potential startups with exceptional facilities and a supportive environment.
For more information about LabCentral, please visit the following web page.
Please contact email@example.com for more information about Braizon business and technology.